Filing Details

Accession Number:
0001179110-13-016290
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-07 16:47:51
Reporting Period:
2013-11-05
Filing Date:
2013-11-07
Accepted Time:
2013-11-07 16:47:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
203077 St Jude Medical Inc STJ Electromedical & Electrotherapeutic Apparatus (3845) 411276891
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
902132 J Daniel Starks One St. Jude Medical Drive
St. Paul MN 55117
Chairman, Ceo & President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-11-05 108,000 $51.91 6,294,116 No 4 M Direct
Common Stock Disposition 2013-11-05 107,795 $57.33 6,186,321 No 4 S Direct
Common Stock Disposition 2013-11-05 205 $58.01 6,186,116 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-11-05 108,000 $0.00 216,000 $51.91
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
108,000 2006-12-13 2013-12-13 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 23, 2013.
  2. Fully vested at the time of filing.
  3. The price in Column 4 is a weighted average. The prices actually received ranged from $56.96 to $57.95. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  4. The price in Column 4 is a weighted average. The prices actually received ranged from $57.98 to $58.02. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.